Christopher D. Heinen, PhDProfessor, Department of MedicineInvestigator, Neag Comprehensive Cancer Center and Center for Molecular Oncology Director of Postdoctoral Affairs
|
Degree | Institution | Major |
---|---|---|
BS | Northwestern University | Biomedical Engineering |
PhD | University of Cincinnati College of Medicine | Molecular Genetics |
Post-Graduate Training
Training | Institution | Specialty |
---|---|---|
Postdoctoral | Thomas Jefferson University |
Awards
Name of Award/Honor | Awarding Organization |
---|---|
Research Scholar Award | American Cancer Society |
Wendy Will Case Cancer Fund Research Grant Award | |
Albert J. Ryan Fellowship Award, 1996-1998 | University of Cincinnati College of Medicine |
Name & Description | Category | Role | Type | Scope | Start Year | End Year |
---|---|---|---|---|---|---|
Health Center Research Advisory Council | Advisory Committee | Chair | UConn Health | University | 2019 | |
American Society for Biochemistry and Molecular Biology Education and Professional Development Committee | Advisory Committee | Member | International | 2019 | ||
NIH ClinGen Sequence Variant Interpretation Working Group | Research Committee | Member | External | National | 2015 | |
International Society for Gastrointestinal Hereditary Tumors Variant Interpretation Committee | Research Committee | External | International | 2011 | ||
The American Society for Microbiology | Professional/Scientific Organization | Member | External | National | 2009 | |
National Institute of General Medical Sciences Minority Biomedical Research Program | Advisory Committee | Ad Hoc Reviewer | External | National | 2009 | |
American Society for Biochemistry and Molecular Biology | Professional/Scientific Organization | External | International | 2009 | ||
American Association for Cancer Research | Professional/Scientific Organization | Member | External | National | 2006 |
Colon cancer is the third most common malignancy in men and women and ranks behind only lung cancer in cancer deaths. The most common hereditary disease that predisposes patients to colorectal cancer is Lynch syndrome (LS) which stems from mutations in the mismatch repair (MMR) genes. In addition to its role in LS, flawed MMR has been implicated in 15-40% of sporadic colorectal and other extracolonic tumors indicating a more general role for MMR in tumor protection. Although many functional details of the MMR proteins have emerged, the mechanism by which flawed MMR contributes to tumorigenesis is not fully understood. Faulty MMR results in an elevated mutation rate (mutator phenotype), which has been proposed to lead to an accumulation of oncogene and tumor suppressor mutations that ultimately cause cancer. More recent work has revealed that MMR proteins play an important role in cell cycle arrest and apoptosis in response to certain DNA damaging agents. Thus, MMR mutations may affect tumorigenesis through multiple mechanisms. Our laboratory is interested in understanding what functions of the MMR system are affected during tumorigenesis.
We are addressing this broad question through a multi-pronged approach. First, we are examining the cellular functions of the MMR proteins and the effects of cancer-causing missense mutations by studying how these mutant proteins perform in DNA repair, cell cycle checkpoint signaling, apoptosis signaling and other functional assays. Most recently, we have begun to characterize the function of the MMR pathway in human pluripotent stem cells and are using CRISPR/Cas9 gene targeting approaches to introduce missense mutations into the endogenous MMR gene loci. Second, we are using pluriopotent stem cells to study the mechanism of the MMR-dependent DNA damage response and how this might impact tumorigenesis. Finally, we are using human colonic organoids to study the effects of MMR mutation on colonic stem cell dynamics and response to damage.
See Dr. Heinen's NBC Connecticut interview on the importance of colon cancer screening on NBC Connecticut at: http://today.uchc.edu/headlines/2010/mar10/coloncancer.html
Not accepting students for Lab Rotations at this time
Lab Rotation Projects
The research in my laboratory involves an array of techniques from cell biology to molecular genetics to genomics to address the fundamental question of why mutations in DNA mismatch repair genes cause cancer. We are predominantly interested in using cancer-associated missense mutations of the MSH2 and MSH6 genes to understand the functions of mismatch repair affected during colorectal tumorigenesis. Projects include:
– Using cell culture models including human pluripotent stem cells to study the functions of mutant MSH2 and MSH6 in damage repair and response.
– Using CRISPR/Cas9 gene engineering to model patient derived missense mutations in the MMR genes in human cells
- Using embryonic stem cells and human colonic organoids to study the effect of MMR mutation on stem cell dynamics
Other projects available and can be discussed depending on student’s interest.
Journal Articles
-
Functional and phenotypic consequences of an unusual inversion in MSH2.
Familial cancer 2023 Nov;
-
Loss of mismatch repair promotes a direct selective advantage in human stem cells.
Stem Cell Reports 2022 Dec;17P2661-2673
-
A calibrated cell-based functional assay to aid classification of MLH1 DNA mismatch repair gene variants.
Human Mutation (Editor's choice) 2022 Dec;43(12):2295-2307
-
Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework.
Genome medicine 2019 Dec;12(1):3
-
Enhanced CRISPR-based DNA demethylation by Casilio-ME-mediated RNA-guided coupling of methylcytosine oxidation and DNA repair pathways.
Nature communications 2019 Sep;10(1):4296
-
Functional Interrogation of Lynch Syndrome Associated MSH2 Missense Variants via CRISPR-Cas9 Gene Editing in Human Embryonic Stem Cells.
Human mutation (Editor's choice) 2019 Jun;
-
The mismatch repair-dependent DNA damage response: Mechanisms and implications.
DNA repair 2019 Apr;7860-69
-
ATR-Chk1 activation mitigates replication stress caused by mismatch repair-dependent processing of DNA damage.
Proceedings of the National Academy of Sciences of the United States of America 2018 Feb;115(7):1523-1528
-
Enhanced gene targeting to evaluate Lynch syndrome alterations.
Proceedings of the National Academy of Sciences of the United States of America 2016 Mar;1133918-20
-
Mismatch repair defects and Lynch syndrome: The role of the basic scientist in the battle against cancer.
DNA repair 2015 Dec;38127-34
-
Milestones of Lynch syndrome: 1895-2015.
Nature reviews. Cancer 2015 Mar;15(3):181-94
-
Human pluripotent stem cells have a novel mismatch repair-dependent damage response.
The Journal of biological chemistry 2014 Jul;289(35):24314-24
-
Translating mismatch repair mechanism into cancer care.
Current drug targets 2014 Jan;15(1):53-64
-
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database.
Nature genetics 2013 Dec;46(2):107-15
-
Response to: Design of a core classification process for DNA mismatch repair variations of a priori unknown functional significance.
Human mutation 2013 Jun;34(6):923-4
-
Pathological assessment of mismatch repair gene variants in Lynch syndrome: past, present, and future.
Human mutation 2012 Dec;33(12):1617-25
-
The predicted truncation from a cancer-associated variant of the MSH2 initiation codon alters activity of the MSH2-MSH6 mismatch repair complex.
Molecular carcinogenesis 2012 Aug;51(8):647-58
-
Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy.
Cancer causes & control : CCC 2012 Feb;23(2):355-61
-
Determining the functional significance of mismatch repair gene missense variants using biochemical and cellular assays.
Hereditary cancer in clinical practice 2012 Jan;10(1):9
-
DNA mismatch repair proteins are required for efficient herpes simplex virus 1 replication.
Journal of virology 2011 Dec;85(23):12241-53
-
Human MSH2 (hMSH2) protein controls ATP processing by hMSH2-hMSH6.
The Journal of biological chemistry 2011 Nov;286(46):40287-95
-
Loss of DNA mismatch repair imparts a selective advantage in planarian adult stem cells.
PloS one 2011 Jan;6(7):e21808
-
Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families.
Mutation research 2010 Nov;693(1-2):32-45
-
Lynch syndrome-associated mutations in MSH2 alter DNA repair and checkpoint response functions in vivo.
Human mutation 2010 Oct;31(10):E1699-708
-
Increased frequency of serrated aberrant crypt foci among smokers.
The American journal of gastroenterology 2010 Jul;105(7):1648-54
-
Nuclear reorganization of DNA mismatch repair proteins in response to DNA damage.
DNA repair 2010 Feb;9(2):120-33
-
Hereditary cancer-associated missense mutations in hMSH6 uncouple ATP hydrolysis from DNA mismatch binding.
The Journal of biological chemistry 2008 Nov;283(46):31641-8
-
Aberrant crypt foci in patients with a positive family history of sporadic colorectal cancer.
Cancer letters 2007 Apr;248(2):262-8
-
Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans.
Cancer research 2007 Apr;67(8):3551-4
-
Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer.
Carcinogenesis 2007 Apr;28(4):769-76
Reviews
-
Contributions of DNA repair and damage response pathways to the non-linear genotoxic responses of alkylating agents.
Mutation research. Reviews in mutation research 2015 Dec;76777-91
Title or Abstract | Type | Sponsor/Event | Date/Year | Location |
---|---|---|---|---|
Panel on Careers in Academia: The pathway(s) to your own lab | Panel Discussion | American Society for Biochemistry and Molecular Biology | 2019 | ASBMB Annual Meeting - Orlando, FL |
The Mechanism of the Mismatch Repair-Dependent DNA Damage Response | Talk | Society of Toxicology 52nd Annual Meeting | 2013 | San Antonio, TX |
The Molecular Mechanism of the Mismatch Repair-Dependent DNA Damage Response | Talk | University of Massachusetts Medical School | 2013 | Worcester, MA |
Panel for Postdoctoral Fellows: The pathway(s) to your own lab | Panel Discussion | American Society for Biochemistry and Molecular Biology Graduate and Postdo | 2013 | Boston, MA |
The Challenge of Mismatch Repair Gene Missense Variants: How Understanding Molecular Mechanism Can Help | Talk | University of Vermont College of Medicine | 2013 | Burlington, VT |
Human Disease as a Model for Mismatch Repair Mechanism | Talk | Environmental Mutagen Society 43rd Annual Meeting | 2012 | Bellevue, Washington |
The Mismatch Repair Molecular Mechanism and the Missense Variant Mystery | Talk | Massachusetts Institute of Technology | 2012 | Cambridge, MA |
Panel for Postdoctoral Fellows: The pathway(s) to your own lab | Panel Discussion | American Society for Biochemistry and Molecular Biology Graduate and Postdo | 2011 | Washington, D.C. |
DNA Mismatch Repair Function in Human Disease | Talk | Hospital Clinico San Carlos, Molecular Oncology Branch | 2011 | Madrid, Spain |
The Molecular Mechanisms of Mismatch Repair | Talk | American Society for Human Genetics Annual Meeting | 2010 | Washington, D.C. |
Reverse Translational Research: What Lynch Syndrome Patients Can Teach Us About Mismatch Repair Mechanism | Talk | Princeton University, Department of Molecular Biology | 2010 | Princeton, NJ |
The Functions of DNA Mismatch Repair Affected in Hereditary Colon Cancer | Talk | Yale University, Department of Molecular Biophysics and Biochemistry | 2010 | New Haven, CT |
The Functions of DNA Mismatch Repair Affected in Hereditary Colon Cancer | Talk | The State University of New York at Buffalo School of Medicine and Biomedical Sciences | 2010 | Buffalo, NY |
Nuclear Reorganization of Mismatch Repair Proteins in Response to DNA Damage | Talk | American Society for Microbiology Conference on DNA Repair and Mutagenesis | 2009 | Whistler, Canada |
The Mechanism of DNA Mismatch Repair: Lessons from Hereditary Non-Polyposis Colon Cancer | Talk | Louisiana State University Health Center, Scott Cancer Center | 2008 | New Orleans, LA |
Hereditary non-polyposis colon cancer and the role of DNA mismatch repair in cancer | Talk | Wesleyan University, Molecular Biology and Biochemistry Department | 2008 | Middletown, CT |